Get the app
US › Healthcare

Incannex Healthcare Inc. (IXHL)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$2.82-2.08%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Net profit
$-12.8M
EPS
$-0.14
EPS estimate
$0.13

EPS came in at -0.14 against a street estimate of 0.13 — a miss of 207.7%.

Key statistics

Market cap
$35.4M
Forward P/E
3.8
P/B
0.55
Book value
$5.37
EPS (TTM)
$-1.62
52-week high
$14.91
52-week low
$2.49
50-day MA
$3.32
200-day MA
$4.73
Beta
2.82

Analyst view

Analysts rate Incannex Healthcare Inc. a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $18.52.

Shareholding

Insiders
11.77%
Institutions
3.64%

Largest institutional holders

FundStake
LPL Financial Corp1.18%
Millennium Management LLC0.76%
Jane Street Group LLC0.62%
AdvisorShares Investments, LLC0.49%
Susquehanna International Group, LLP0.23%
Commonwealth Equity Services, LLC0.11%
Citadel Advisors Llc0.08%
Advisor Group Holdings, Inc.0.05%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Incannex Healthcare Inc. — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.